New inhaler drug HRS-9821 enters first human tests for COPD
NCT ID NCT07567872
First seen May 12, 2026 · Last updated May 24, 2026 · Updated 2 times
Summary
This early-stage study tests a new inhaled medicine called HRS-9821 for COPD. It will first check safety in 48 healthy volunteers and then in people with COPD. The goal is to see if the drug is safe and how it moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610044, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.